Biotron (OTC: BITRF)
$0.01
(251.9%)
$0.01
Price as of May 16, 2025, 10:29 a.m. ET
Biotron Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Biotron Company Info
Biotron Ltd. operates as a clinical stage biotechnology company. It engages in developing and commercializing a novel small molecule approach that treats serious viral disease. The firm's technology targets viroporin proteins, which enables the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and respiratory syncytial virus. Its proprietary bacterial cell-based screening platform enables rapid screening for target viroporin proteins. The company was founded in February 1999 and is headquartered in North Ryde, Australia.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.